Systematic review and network meta-analysis of the risk of Herpes zoster with biological therapies and selective Janus kinase-1 inhibitors in atopic dermatitis
CONCLUSIONS: JAK-1 inhibitors are associated with a significantly higher incidence of HZ compared to dupilumab and placebo. Our results suggest that recombinant HZ vaccination should be highly considered for all adult patients prior to starting oral JAK-1 inhibitors.PMID:38533363 | PMC:PMC10962383 | DOI:10.5114/ada.2023.135764
Source: Advances in Dermatology and Allergology - Category: Dermatology Authors: Daud Manzar Nikhil Nair Emmanuel Suntres Myanca Rodrigues Mohannad Abu-Hilal Source Type: research
More News: Dermatitis | Dermatology | Herpes | Shingles (Herpes Zoster) Vaccine | Skin | Vaccines | Varicella-Zoster Virus Vaccine